Analyst Research

Report Title Price
Provider: Reuters Investment Profile
Provider: Wright Reports
Provider: GlobalData
Provider: GlobalData

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Pacgen Life Science Corp Appoints Interim Chief Executive Officer

Wednesday, 8 May 2013 09:00pm EDT 

Pacgen Life Science Corp announced that Dr. Ming S. Liu has stepped down as Chief Executive Officer of the Company, effectively immediately. The Company has appointed Mr. Chung-Yu Wang, current Chairman and Director of Pacgen, as Interim Chief Executive Officer. Dr. Liu has elected to step down from his operational roles due to personal reasons. He will continue to serve as a Director of Pacgen. 

Company Quote

0.0 +0.00%
23 Jul 2014